Last update 01 Nov 2024

p38 MAPK x PDE4 x A1R

Basic Info

Related Targets
p38 MAPKPDE4A1R

Related

1
Drugs associated with p38 MAPK x PDE4 x A1R
CGH-2466
Target
A1R x PDE4 x p38 MAPK
Mechanism
A1R antagonists [+2]
Active Org.-
Originator Org.
Novartis AGNovartis AG
Active Indication-
Inactive Indication
Asthma [+1]
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with p38 MAPK x PDE4 x A1R
Login to view more data
100 Translational Medicine associated with p38 MAPK x PDE4 x A1R
Login to view more data
0 Patents (Medical) associated with p38 MAPK x PDE4 x A1R
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free